SCHEMBL26963095

SCHEMBL26963095

CS(=O)(=O)N1CC2CC2(c2nnc(-c3cc4c(cc3F)S(=O)(=O)C(COC(=O)N3CC5CC5(c5nnc(-c6cc7c(cc6F)S(=O)(=O)C[C@H](N)C(=O)N7Cc6ccc(Cl)cc6)o5)C3)[C@H](N)C(=O)N4Cc3ccc(Cl)cc3)o2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29796432 0.91 — —
SCHEMBL26961376 0.90 — —
SCHEMBL26961316 0.88 — —
Trifluoroacetic Acid SCHEMBL26961643 0.86 — —
SCHEMBL31142921 0.85 — —
SCHEMBL31142773 0.84 — —
SCHEMBL26961195 0.83 TP53 (0.32) —
SCHEMBL26961475 0.81 — —
SCHEMBL29796451 0.80 — —
SCHEMBL26961328 0.80 THRB (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback